 analysis lymphocyte binding neurological patients Evidence altered binding Alzheimer disease Muscarinic cholinergic receptors lymphocyte membranes patients early late onset Alzheimer disease AD patients neurological disorders normal controls specific binding number sites Bmax late onset AD groups age-matched controls apparent binding affinity Kd disease control groups addition average Bmax early AD late AD density binding subgroup old subjects Down syndrome DS changes individuals DS patients Parkinson disease multi-infarct dementia myasthenia gravis epilepsy AD group difference sites unrelated severity dementia disease duration Treatment patients cholinergic agents binding values examined group alteration lymphocyte muscarinic receptors AD central cholinergic deficit patients uncertain